Our Commitment to Access and Affordability
Gilead is a bridge to a healthier world. We have an enduring commitment to delivering care and choice to the people and places that need it most. We collaborate with communities to reduce barriers to healthcare.
We have programs in the U.S. and in many countries to help ease the burden for patients and families navigating the healthcare landscape. These programs enhance access to medicines across our therapeutic areas, providing options such as co-pay assistance, counseling and low-cost or free therapies.
Access in the U.S.
Patient Support Programs
We offer support navigating access and coverage for individuals who are unsure if their insurance plan provides coverage or affordable co-pays to our medicines. Our case managers help individuals understand what their insurance will cover and provide research on potential alternative coverage and co-pay support.
We also provide access to Gilead medications at no cost for eligible, uninsured individuals.
View U.S. Patient Support ProgramsAssistance for Individuals Living with HIV
Approximately half of all individuals taking Gilead HIV medicines in the United States receive them through federal and state programs at substantially discounted prices. We have a long history of working with state AIDS Drug Assistance Programs (ADAP) to provide lower pricing for our HIV medicines.
The Gilead Advancing Access® program offers HIV treatment and HIV prevention (PrEP) patient support, including potential options for people without insurance and co-pay assistance for eligible people with commercial insurance.
View Gilead Advancing AccessManaged Access
Managed access provides eligible patients with serious or life-threatening conditions with access to medicinal products for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. Managed access encompasses compassionate use, expanded access, early access and individual patient use.
View Managed Access
Access to our Medicines in
Low- and Middle-Income
Countries
We forge connections between patients and their communities — across borders, between public health providers and private industry — to create solutions that address critical health inequities in low- and middle-income countries. We build innovative, sustainable programs that enable long-term access for millions of people and empower our partners doing work on the ground so that life-changing treatments for HIV, viral hepatitis and invasive fungal infections get to those who need them most.
To increase education and disease awareness, engage partners strategically and deliver medicines efficiently, we:
- Implement tiered pricing with discounts on medicines based on disease burden and national per-capita income
- Pursue responsible generic licensing of our products to enable high-quality, low-cost versions of our HIV and viral hepatitis medicines for individuals in low- and middle-income countries
- Strengthen health systems to overcome access barriers by bolstering diagnostic, treatment and surveillance capacity
- Invest in programs that improve services for communities heavily affected by disease
- Support collaborative research with international and local research leaders to target innovative therapies, inform drug delivery and help countries map their disease burdens
- Partner with governments and non-governmental organizations to amplify our impact as well as collaboration with in-country distributors that help register products and forecast drug demand
- Advocate for public health initiatives and policies that maximize patient reach and prevent new infections
GLOBAL IMPACT
Helping People Overcome Barriers to Treatment in More Than 140 Low- and Middle-Income Countries
Hepatitis C medicines made available in 64 countries through 2024 through Gilead's voluntary licensing program
Treatments for COVID-19 made available in more than 65 countries through 2024 through Gilead's voluntary licensing program
Treatments are made available for patients in up to 127 countries each year through Gilead's voluntary licensing program
Global Operations
As a global company, we offer access and operate in many regions around the world.
Strategic Initiatives
We collaborate with communities around the world to expand access and improve health equity.